Author:
Sharma Meemansha,Singh Thakur Uttam,Lingaraju Madhu Cholanhalli,Parida Subhashree
Reference55 articles.
1. Hoeper MM, Ghofrani HA, Grünig E, Klose H, Olschewski H, Rosenkranz S (2017) Pulmonary hypertension. Dtsch Arztebl Int 114(5):73
2. Thenappan T, Chan SY, Weir EK (2018) Role of extracellular matrix in the pathogenesis of pulmonary arterial hypertension. Am J Phys Heart Circ Phys 315(5):H1322–H1331
3. Prins KW, Thenappan T (2016) WHO Group I pulmonary hypertension: epidemiology and pathophysiology. Cardiol Clin 34(3):363
4. Schermuly RT, Ghofrani HA, Wilkins MR, Grimminger F (2011) Mechanisms of disease: pulmonary arterial hypertension. Nat Rev Cardiol 8(8):443
5. Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R (2019) Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 53:1